Lifetime Costs of Septal Reduction Therapies are Substantially Lower Compared to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy

被引：0
|
作者：
Daaboul, Yazan [1 ]
Rowin, Ethan [2 ]
Maron, Martin [2 ]
Kimmelstiel, Carey [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
[2] Lahey Hosp & Med Ctr, Burlington, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 80卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-355
引用
收藏
页码：B144 / B144
页数：1
相关论文
共 50 条
  • [31] CYANOACRYLATE FOR NONSURGICAL SEPTAL REDUCTION THERAPY IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Oto, A.
    Aytemir, K.
    Okutucu, S.
    Cil, B.
    Peynircioglu, B.
    Kaya, E. B.
    Deniz, A.
    Evranos, B.
    Sahiner, L.
    Kabakci, G.
    Tokgozoglu, L.
    Ozkutlu, H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S70 - S71
  • [32] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy - Response
    Sigwart, U
    CIRCULATION, 1998, 97 (07) : 709 - 709
  • [33] SYSTEMATIC LITERATURE REVIEW OF THE EFFICACY AND SAFETY OF PHARMACOLOGICAL TREATMENTS AND SEPTAL REDUCTION THERAPIES FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Spoorendonk, J. A.
    Sahbaz Gulser, S.
    Arca, E.
    Hurst, M.
    Zema, C.
    Contente, M.
    Krause, T.
    VALUE IN HEALTH, 2022, 25 (12) : S368 - S368
  • [34] SAFETY OF ALCOHOL SEPTAL ABLATION FOR SEPTAL REDUCTION PRIOR TO TRANSCATHETER MITRAL VALVE REPLACEMENT COMPARED TO OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Elhadi, Mohamed
    Guerrero, Mayra E.
    Rihal, Charanjit S.
    Eleid, Mackram F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 583 - 583
  • [35] SEX DIFFERENCES IN PATIENT SELECTION AND OUTCOMES OF SEPTAL REDUCTION THERAPIES FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN THE UNITED STATES
    Sreenivasan, Jayakumar
    Hooda, Urvashi
    Kaur, Simrat
    Sharma, Sachit
    Aronow, Wilbert S.
    Cooper, Howard A.
    Naidu, Srihari
    Panza, Julio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 949 - 949
  • [36] Outcome of septal myectomy in patients with hypertrophic obstructive cardiomyopathy
    Havndrup, O
    Pettersson, G
    Kjeldsen, K
    Bundgaard, H
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2000, 34 (06) : 564 - 569
  • [37] Untoward effect of septal reduction interventions on conduction system in patients with obstructive hypertrophic cardiomyopathy
    Qin, JX
    Shiota, T
    Lever, HM
    Greenberg, NL
    Agler, DA
    Drinko, JK
    Martin, M
    Schnauffer, MJ
    Smedira, NG
    Tuzcu, EM
    Lytle, B
    Thomas, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 132A - 132A
  • [38] The incidence of conduction system block after septal reduction in patients with hypertrophic obstructive cardiomyopathy
    Qin, JX
    Shiota, T
    Asher, CR
    Agler, DA
    Drinko, JK
    Smedira, NG
    Tuzcu, EM
    Lytle, BW
    Lever, HM
    CIRCULATION, 2002, 106 (19) : 655 - 655
  • [39] Reoperation Was an Effective Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy After Septal Reduction Therapy
    Zhang, Yang
    Zhu, Changsheng
    Song, Changpeng
    Yin, Kunlun
    Zhang, Jian
    Huang, Manyun
    Zheng, Xinxin
    Lu, Jie
    Fang, Xiaonan
    Zhou, Zhou
    Wang Shuiyun
    Huang, Xiaohong
    CIRCULATION, 2021, 144
  • [40] Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions
    Qin, JX
    Shiota, T
    Lever, HM
    Asher, CR
    Popovic, ZB
    Greenberg, NL
    Agler, DA
    Drinko, JK
    Smedira, NG
    Tuzcu, EM
    Lytle, BW
    Thomas, JD
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (02): : 171 - 175
12345